Sara Y. Tartof, Ph.D.
Affiliations: | 2010 | Epidemiology | University of California, Berkeley, Berkeley, CA, United States |
Area:
Microbiology, Immunology, Public HealthGoogle:
"Sara Tartof"Cross-listing: PHTree
Parents
Sign in to add mentor| Lee W. Riley | grad student | 2010 | UC Berkeley | |
| (Rheumatic Heart Disease and Beta-hemolytic Streptococci in Salvador, Brazil: A Study of Slum Health.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Frutos AM, Price AM, Harker E, et al. (2024) Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. Mmwr. Morbidity and Mortality Weekly Report. 73: 168-174 |
| Sumner KM, Yadav R, Noble EK, et al. (2024) Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of Infectious Diseases |
| Sandford R, Yadav R, Noble EK, et al. (2023) Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences |
| Ahmed F, Nowalk MP, Zimmerman RK, et al. (2023) Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. Emerging Infectious Diseases. 29 |
| Sumner KM, Yadav R, Noble EK, et al. (2023) Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences |
| Tartof SY, Xie F, Yadav R, et al. (2023) Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and Other Respiratory Viruses. 17: e13143 |
| Tartof SY, Xie F, Yadav R, et al. (2023) Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. Medrxiv : the Preprint Server For Health Sciences |
| Kim SS, Chung JR, Talbot HK, et al. (2022) Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and Other Respiratory Viruses. 16: 975-985 |
| Price AM, Flannery B, Talbot HK, et al. (2022) Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Chung JR, Kim SS, Kondor RJ, et al. (2022) Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 365-370 |